Report Detail
Global Epigenetics Market Insights, Forecast to 2025
- RnM3518141 |
- 12 June, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Based on product, the global market for epigenetics, is segmented into enzymes, instruments and consumables, kits, reagents, and bioinformatics tools. In 2017, the kits segment accounted for the largest share of global market for epigenetics. The large share of this segment is attributed to the fact that a large number of kits are used in epigenetic techniques. The rising prevalence of a number of diseases, increasing R&D spending, and increased government funding for life science research are the other factors supporting market growth.
Market growth can be attributed to the decreasing sequencing costs, increase in research activities, availability of funding for epigenetics research, and rising prevalence of cancer.
The global Epigenetics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of 4.8% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Epigenetics market based on company, product type, end user and key regions.
This report studies the global market size of Epigenetics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Epigenetics in these regions.
This research report categorizes the global Epigenetics market by top players/brands, region, type and end user. This report also studies the global Epigenetics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Illumina
Thermo Fisher Scientific
Merck Millipore
Abcam
Active Motif
Bio-Rad
New England Biolabs
Agilent
Qiagen
Zymo Research
Perkinelmer
Diagenode
Market size by Product
DNA Methylation
Histone Modifications
Other Technologies
Market size by End User
Oncology
Metabolic Diseases
Developmental Biology
Immunology
Cardiovascular Diseases
Other Applications
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Epigenetics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Epigenetics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Epigenetics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Epigenetics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Epigenetics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Epigenetics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Epigenetics Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Epigenetics Market Size Growth Rate by Product
- 1.4.2 DNA Methylation
- 1.4.3 Histone Modifications
- 1.4.4 Other Technologies
- 1.5 Market by End User
- 1.5.1 Global Epigenetics Market Size Growth Rate by End User
- 1.5.2 Oncology
- 1.5.3 Metabolic Diseases
- 1.5.4 Developmental Biology
- 1.5.5 Immunology
- 1.5.6 Cardiovascular Diseases
- 1.5.7 Other Applications
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Epigenetics Market Size
- 2.1.1 Global Epigenetics Revenue 2014-2025
- 2.1.2 Global Epigenetics Sales 2014-2025
- 2.2 Epigenetics Growth Rate by Regions
- 2.2.1 Global Epigenetics Sales by Regions
- 2.2.2 Global Epigenetics Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Epigenetics Sales by Manufacturers
- 3.1.1 Epigenetics Sales by Manufacturers
- 3.1.2 Epigenetics Sales Market Share by Manufacturers
- 3.1.3 Global Epigenetics Market Concentration Ratio (CR5 and HHI)
- 3.2 Epigenetics Revenue by Manufacturers
- 3.2.1 Epigenetics Revenue by Manufacturers (2014-2019)
- 3.2.2 Epigenetics Revenue Share by Manufacturers (2014-2019)
- 3.3 Epigenetics Price by Manufacturers
- 3.4 Epigenetics Manufacturing Base Distribution, Product Types
- 3.4.1 Epigenetics Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Epigenetics Product Type
- 3.4.3 Date of International Manufacturers Enter into Epigenetics Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Epigenetics Sales by Product
- 4.2 Global Epigenetics Revenue by Product
- 4.3 Epigenetics Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Epigenetics Breakdown Data by End User
6 North America
- 6.1 North America Epigenetics by Countries
- 6.1.1 North America Epigenetics Sales by Countries
- 6.1.2 North America Epigenetics Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Epigenetics by Product
- 6.3 North America Epigenetics by End User
7 Europe
- 7.1 Europe Epigenetics by Countries
- 7.1.1 Europe Epigenetics Sales by Countries
- 7.1.2 Europe Epigenetics Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Epigenetics by Product
- 7.3 Europe Epigenetics by End User
8 Asia Pacific
- 8.1 Asia Pacific Epigenetics by Countries
- 8.1.1 Asia Pacific Epigenetics Sales by Countries
- 8.1.2 Asia Pacific Epigenetics Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Epigenetics by Product
- 8.3 Asia Pacific Epigenetics by End User
9 Central & South America
- 9.1 Central & South America Epigenetics by Countries
- 9.1.1 Central & South America Epigenetics Sales by Countries
- 9.1.2 Central & South America Epigenetics Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Epigenetics by Product
- 9.3 Central & South America Epigenetics by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Epigenetics by Countries
- 10.1.1 Middle East and Africa Epigenetics Sales by Countries
- 10.1.2 Middle East and Africa Epigenetics Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Epigenetics by Product
- 10.3 Middle East and Africa Epigenetics by End User
11 Company Profiles
- 11.1 Illumina
- 11.1.1 Illumina Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Illumina Epigenetics Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Illumina Epigenetics Products Offered
- 11.1.5 Illumina Recent Development
- 11.2 Thermo Fisher Scientific
- 11.2.1 Thermo Fisher Scientific Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Thermo Fisher Scientific Epigenetics Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Thermo Fisher Scientific Epigenetics Products Offered
- 11.2.5 Thermo Fisher Scientific Recent Development
- 11.3 Merck Millipore
- 11.3.1 Merck Millipore Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Merck Millipore Epigenetics Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Merck Millipore Epigenetics Products Offered
- 11.3.5 Merck Millipore Recent Development
- 11.4 Abcam
- 11.4.1 Abcam Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Abcam Epigenetics Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Abcam Epigenetics Products Offered
- 11.4.5 Abcam Recent Development
- 11.5 Active Motif
- 11.5.1 Active Motif Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Active Motif Epigenetics Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Active Motif Epigenetics Products Offered
- 11.5.5 Active Motif Recent Development
- 11.6 Bio-Rad
- 11.6.1 Bio-Rad Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Bio-Rad Epigenetics Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Bio-Rad Epigenetics Products Offered
- 11.6.5 Bio-Rad Recent Development
- 11.7 New England Biolabs
- 11.7.1 New England Biolabs Company Details
- 11.7.2 Company Business Overview
- 11.7.3 New England Biolabs Epigenetics Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 New England Biolabs Epigenetics Products Offered
- 11.7.5 New England Biolabs Recent Development
- 11.8 Agilent
- 11.8.1 Agilent Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Agilent Epigenetics Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Agilent Epigenetics Products Offered
- 11.8.5 Agilent Recent Development
- 11.9 Qiagen
- 11.9.1 Qiagen Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Qiagen Epigenetics Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Qiagen Epigenetics Products Offered
- 11.9.5 Qiagen Recent Development
- 11.10 Zymo Research
- 11.10.1 Zymo Research Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Zymo Research Epigenetics Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Zymo Research Epigenetics Products Offered
- 11.10.5 Zymo Research Recent Development
- 11.11 Perkinelmer
- 11.12 Diagenode
12 Future Forecast
- 12.1 Epigenetics Market Forecast by Regions
- 12.1.1 Global Epigenetics Sales Forecast by Regions 2019-2025
- 12.1.2 Global Epigenetics Revenue Forecast by Regions 2019-2025
- 12.2 Epigenetics Market Forecast by Product
- 12.2.1 Global Epigenetics Sales Forecast by Product 2019-2025
- 12.2.2 Global Epigenetics Revenue Forecast by Product 2019-2025
- 12.3 Epigenetics Market Forecast by End User
- 12.4 North America Epigenetics Forecast
- 12.5 Europe Epigenetics Forecast
- 12.6 Asia Pacific Epigenetics Forecast
- 12.7 Central & South America Epigenetics Forecast
- 12.8 Middle East and Africa Epigenetics Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Epigenetics Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Epigenetics . Industry analysis & Market Report on Epigenetics is a syndicated market report, published as Global Epigenetics Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Epigenetics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
